The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

IXI IXICO PLC ORD 1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 16-Nov-2016 IXI Participation in major EU partnership (ROADMAP) RNS +4.49% Up
07:00 21-Oct-2016 IXI Pre-Close Trading Update RNS +7.05% Up
07:00 20-Oct-2016 IXI $1.2m contract with new global pharma customer RNS +14.07% Up
07:00 19-Oct-2016 IXI IXICO presents at CAMD regulatory workshop RNS +13.04% Up
07:00 10-Oct-2016 IXI EUR1m funding as a partner in major EU consortium RNS -5.24% Down
07:00 03-Oct-2016 IXI Appointment of Shore Capital as Nominated Adviser RNS -3.13% Down
07:00 03-Oct-2016 IXI Appointment of Shore Capital RNS -3.13% Down
17:14 26-Sep-2016 IXI Director/PDMR Shareholding RNS -2.29% Down
13:58 26-Sep-2016 IXI Exercise of Share Options RNS -2.29% Down
07:00 16-Sep-2016 IXI Board changes RNS -
07:00 13-Sep-2016 IXI Presentation of Assessa® PML at ECTRIMS RNS -9.41% Down
10:25 29-Jul-2016 IXI Web-Based Technology Improves Paediatric ADHD Care RNS +1.25% Up
07:00 07-Jun-2016 IXI Half Yearly Report to 31 March 2016 RNS -4.56% Down
07:00 02-Jun-2016 IXI Cygnus joins Dementias Platform UK RNS -1.36% Down
07:00 04-Apr-2016 IXI Consortium and Five Year Contract RNS +0.96% Up
07:00 31-Mar-2016 IXI Real world study of Digital Biomarkers RNS +0.60% Up
07:00 31-Mar-2016 IXI Grant of Awards to Directors RNS +0.60% Up
07:00 30-Mar-2016 IXI NHS emergency and out-of-hours services contract RNS +1.20% Up
09:30 09-Mar-2016 IXI European research to tackle dementia RNS +1.53% Up
07:00 03-Mar-2016 IXI Mehealth® used in American Academy of Pediatrics RNS +1.55% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 4th Floor, Griffin Court, 15 Long Lane, London, EC1A 9PN, United Kingdom
Company website http://www.ixico.com
Market cap(in millions)* £ 11.62
Listing/Admission to trading 15 Oct 2013
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-Dec-16
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 1,000
SEDOL BCLY7L4
ISIN number GB00BCLY7L40



IXICO share news analysis (IXI)